Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Short term Debt: 2020-2023

Historic Short term Debt for Candel Therapeutics (CADL) over the last 1 years, with Sep 2023 value amounting to $6.1 million.

  • Candel Therapeutics' Short term Debt was N/A to $6.1 million in Q3 2023 from the same period last year, while for Sep 2023 it was $6.1 million, marking a year-over-year change of. This contributed to the annual value of $463,000 for FY2020, which is N/A change from last year.
  • Candel Therapeutics' Short term Debt amounted to $6.1 million in Q3 2023, which was up 67.03% from $3.7 million recorded in Q2 2023.
  • In the past 5 years, Candel Therapeutics' Short term Debt ranged from a high of $6.1 million in Q3 2023 and a low of $463,000 during Q4 2020.
  • Moreover, its 1-year median value for Short term Debt was $3.7 million (2023), whereas its average is $3.7 million.